Structural characterization of H-1 parvovirus: Comparison of infectious virions to empty capsids

Journal of Virology

Volumn 87, Issue 9, 2013, Pages 5128-5140

  Halder, Sujata ^a   Nam, Hyun Joo ^a,c   Govindasamy, Lakshmanan ^a   Vogel, Michèle ^b,d   Dinsart, Christiane ^b   Salomé, Nathalie ^b   McKenna, Robert ^a   Agbandje McKenna, Mavis ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c The University of Texas at Dallas   (United States)

^d INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; SINGLE STRANDED DNA;

ALPHA HELIX; ARTICLE; BETA SHEET; CONTROLLED STUDY; DNA PACKAGING; H-1 PARVOVIRUS; MOLECULAR EVOLUTION; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; NUCLEOTIDE BINDING SITE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN CONFORMATION; PROTEIN DNA BINDING; PROTEIN FUNCTION; PROTEIN STABILITY; RECEPTOR BINDING; RESIDUE ANALYSIS; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; VIRAL TROPISM; VIRION; VIRUS CAPSID; VIRUS CELL INTERACTION; VIRUS GENOME; X RAY CRYSTALLOGRAPHY;

AMINO ACID SEQUENCE; CAPSID; CAPSID PROTEINS; CRYSTALLOGRAPHY, X-RAY; H-1 PARVOVIRUS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN CONFORMATION; VIRION;

CANINE PARVOVIRUS; H-1 PARVOVIRUS; MINUTE VIRUS OF MICE; MIRIDAE; PARVOVIRUS; RODENT PARVOVIRUSES;

EID: 84876305036     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03416-12     Document Type: Article

References (96)

1. Berns K, Parrish CR. 2007. Parvoviridae, p 2437-2478. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
2. Toolan HW, Dalldore G, Barclay M, Chandra S, Moore AE. 1960. An unidentified, filtrable agent isolated from transplanted human tumors. Proc. Natl. Acad. Sci. U. S. A. 46:1256 -1258.
3. Toolan HW. 1968. The picodna viruses. H, RV, and AAV. Int. Rev. Exp. Pathol. 6:135-180.
4. Blechacz B, Russell SJ. 2004. Parvovirus vectors: use and optimisation in cancer gene therapy. Expert Rev. Mol. Med. 6:1-24.
5. Rommelaere J, Geletneky K, Angelova AL, Daeffler L, Dinsart C, Kiprianova I, Schlehofer JR, Raykov Z. 2010. Oncolytic parvoviruses as cancer therapeutics. Cytokine Growth Factor Rev. 21:185-195.
6. Spalholz BA, Tattersall P. 1983. Interaction of minute virus of mice with differentiated cells: strain-dependent target cell specificity is mediated by intracellular factors. J. Virol. 46:937-943.
7. Cotmore SF, Tattersall P. 1987. The autonomously replicating parvoviruses of vertebrates. Adv. Virus Res. 33:91-174.
8. Angelova AL, Aprahamian M, Balboni G, Delecluse HJ, Feederle R, Kiprianova I, Grekova SP, Galabov AS, Witzens-Harig M, Ho AD, Rommelaere J, Raykov Z. 2009. Oncolytic rat parvovirus H-1PV, a candidate for the treatment of human lymphoma: in vitro and in vivo studies. Mol. Ther. 17:1164 -1172.
9. Angelova AL, Aprahamian M, Grekova SP, Hajri A, Leuchs B, Giese NA, Dinsart C, Herrmann A, Balboni G, Rommelaere J, Raykov Z. 2009. Improvement of gemcitabine-based therapy of pancreatic carcinoma by means of oncolytic parvovirus H-1PV. Clin. Cancer Res. 15:511-519.
10. Faisst S, Guittard D, Benner A, Cesbron JY, Schlehofer JR, Rommelaere J, Dupressoir T. 1998. Dose-dependent regression of HeLa cell-derived tumours in SCID mice after parvovirus H-1 infection. Int. J. Cancer 75: 584-589.
11. Herrero Y Calle M, Cornelis JJ, Herold-Mende C, Rommelaere J, Schlehofer JR, Geletneky K. 2004. Parvovirus H-1 infection of human glioma cells leads to complete viral replication and efficient cell killing. Int. J. Cancer 109:76-84.
12. Malerba M, Daeffler L, Rommelaere J, Iggo RD. 2003. Replicating parvoviruses that target colon cancer cells. J. Virol. 77:6683- 6691.
13. Van Pachterbeke C, Tuynder M, Brandenburger A, Leclercq G, Borras M, Rommelaere J. 1997. Varying sensitivity of human mammary carcinoma cells to the toxic effect of parvovirus H-1. Eur. J. Cancer 33:1648-1653.
14. Enderlin M, Kleinmann EV, Struyf S, Buracchi C, Vecchi A, Kinscherf R, Kiessling F, Paschek S, Sozzani S, Rommelaere J, Cornelis JJ, Van Damme J, Dinsart C. 2009. TNF-α and the IFN-γ-inducible protein 10 (IP-10/CXCL-10) delivered by parvoviral vectors act in synergy to induce antitumor effects in mouse glioblastoma. Cancer Gene Ther. 16:149 -160.
15. Haag A, Menten P, Van Damme J, Dinsart C, Rommelaere J, Cornelis JJ. 2000. Highly efficient transduction and expression of cytokine genes in human tumor cells by means of autonomous parvovirus vectors; generation of antitumor responses in recipient mice. Hum. Gene Ther. 11:597-609.
16. Moehler M, Sieben M, Roth S, Springsguth F, Leuchs B, Zeidler M, Dinsart C, Rommelaere J, Galle PR. 2011. Activation of the human immune system by chemotherapeutic or targeted agents combined with the oncolytic parvovirus H-1. BMC Cancer 11:464. doi:10.1186/1471 -2407-11-464.
17. Moehler M, Zeidler M, Schede J, Rommelaere J, Galle PR, Cornelis JJ, Heike M. 2003. Oncolytic parvovirus H1 induces release of heat-shock protein HSP72 in susceptible human tumor cells but may not affect primary immune cells. Cancer Gene Ther. 10:477- 480.
18. Olijslagers S, Dege AY, Dinsart C, Voorhoeve M, Rommelaere J, Noteborn MH, Cornelis JJ. 2001. Potentiation of a recombinant oncolytic parvovirus by expression of Apoptin. Cancer Gene Ther. 8:958 -965.
19. Wetzel K, Menten P, Opdënakker G, Van Damme J, Gröne HJ, Giese N, Vecchi A, Sozzani S, Cornelis JJ, Rommelaere J, Dinsart C. 2001. Transduction of human MCP-3 by a parvoviral vector induces leukocyte infiltration and reduces growth of human cervical carcinoma cell xenografts. J. Gene Med. 3:326 -337.
20. Toolan HW, Saunders EL, Southam CM, Moore AE, Levin AG. 1965. H-1 virus viremia in the human. Proc. Soc. Exp. Biol. Med. 119:711-715.
21. Lacroix J, Leuchs B, Li J, Hristov G, Deubzer HE, Kulozik AE, Rommelaere J, Schlehofer JR, Witt O. 2010. Parvovirus H1 selectively induces cytotoxic effects on human neuroblastoma cells. Int. J. Cancer 127:1230-1239.
22. Moehler M, Blechacz B, Weiskopf N, Zeidler M, Stremmel W, Rommelaere J, Galle PR, Cornelis JJ. 2001. Effective infection, apoptotic cell killing and gene transfer of human hepatoma cells but not primary hepatocytes by parvovirus H1 and derived vectors. Cancer Gene Ther. 8:158-167.
23. Geletneky K, Kiprianova I, Ayache A, Koch R, Herrero Y Calle M, Deleu L, Sommer C, Thomas N, Rommelaere J, Schlehofer JR. 2010. Regression of advanced rat and human gliomas by local or systemic treatment with oncolytic parvovirus H-1 in rat models. Neurol. Oncol. 12: 804-814.
24. Kiprianova I, Thomas N, Ayache A, Fischer M, Leuchs B, Klein M, Rommelaere J, Schlehofer JR. 2011. Regression of glioma in rat models by intranasal application of parvovirus H-1. Clin. Cancer Res. 17:5333-5342.
25. Geletneky K, Huesing J, Rommelaere J, Schlehofer JR, Leuchs B, Dahm M, Krebs O, von Knebel Doeberitz M, Huber B, Hajda J. 2012. Phase I/IIa study of intratumoral/intracerebral or intravenous/intracerebral administration of parvovirus H-1 (ParvOryx) in patients with progressive primary or recurrent glioblastoma multiforme: ParvOryx01 protocol. BMC Cancer 12:99. doi:10.1186/1471-2407-12-99.
26. Legrand C, Rommelaere J, Caillet-Fauquet P. 1993. MVM(p) NS-2 protein expression is required with NS-1 for maximal cytotoxicity in human transformed cells. Virology 195:149 -155.
27. Tattersall P, Cawte PJ, Shatkin AJ, Ward DC. 1976. Three structural polypeptides coded for by minute virus of mice, a parvovirus. J. Virol. 20:273-289.
28. Agbandje M, McKenna R, Rossmann MG, Strassheim ML, Parrish CR. 1993. Structure determination of feline panleukopenia virus empty particles. Proteins 16:155-171.
29. Agbandje-McKenna M, Llamas-Saiz AL, Wang F, Tattersall P, Rossmann MG. 1998. Functional implications of the structure of the murine parvovirus, minute virus of mice. Structure 6:1369 -1381.
30. Govindasamy L, Hueffer K, Parrish CR, Agbandje-McKenna M. 2003. Structures of host range-controlling regions of the capsids of canine and feline parvoviruses and mutants. J. Virol. 77:12211-12221.
31. Kontou M, Govindasamy L, Nam HJ, Bryant N, Llamas-Saiz AL, Foces-Foces C, Hernando E, Rubio MP, McKenna R, Almendral JM, Agbandje-McKenna M. 2005. Structural determinants of tissue tropism and in vivo pathogenicity for the parvovirus minute virus of mice. J. Virol. 79:10931-10943.
32. Simpson AA, Chandrasekar V, Hébert B, Sullivan GM, Rossmann MG, Parrish CR. 2000. Host range and variability of calcium binding by surface loops in the capsids of canine and feline parvoviruses. J. Mol. Biol. 300: 597-610.
33. Simpson AA, Hébert B, Sullivan GM, Parrish CR, Zádori Z, Tijssen P, Rossmann MG. 2002. The structure of porcine parvovirus: comparison with related viruses. J. Mol. Biol. 315:1189 -1198.
34. Tsao J, Chapman MS, Agbandje M, Keller W, Smith K, Wu H, Luo M, Smith TJ, Rossmann MG, Compans RW, Parrish CR. 1991. The threedimensional structure of canine parvovirus and its functional implications. Science 251:1456 -1464.
35. Wu H, Rossmann MG. 1993. The canine parvovirus empty capsid structure. J. Mol. Biol. 233:231-244.
36. Xie Q, Chapman MS. 1996. Canine parvovirus capsid structure, analyzed at 2.9 Å resolution. J. Mol. Biol. 264:497-520.
37. Kaufmann B, Chipman PR, Kostyuchenko VA, Modrow S, Rossmann MG. 2008. Visualization of the externalized VP2 N termini of infectious human parvovirus B19. J. Virol. 82:7306 -7312.
38. Chapman MS, Agbandje-McKenna M. 2006. Atomic structure of viral particles, p 107-123. In Kerr JR, Cotmore SF, Bloom ME, Linden RM, Parrish CR (ed), Parvoviruses. Hodder Arnold, London, United Kingdom.
39. Agbandje-McKenna M, Chapman MS. 2006. Correlating structure with function in viral capsid, p 125-139. In Kerr JR, Cotmore SF, Bloom ME, Linden RM, Parrish CR (ed), Parvoviruses. Hodder Arnold, London, United Kingdom.
40. Halder S, Nam HJ, Govindasamy L, Vogel M, Dinsart C, Salomé N, McKenna R, Agbandje-McKenna M. 2012. Production, purification, crystallization and structure determination of H-1 parvovirus. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 68:1571-1576.
41. Otwinowski Z, Minor W. 1997. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276:307-326.
42. Matthews BW. 1968. Solvent content of protein crystals. J. Mol. Biol. 33:491- 497.
43. Navaza J. 2001. Implementation of molecular replacement in AMoRe. Acta Crystallogr. D. Biol. Crystallogr. 57:1367-1372.
44. Brünger AT, Adams PD, Clore GM, DeLano WL, Gros P, Grosse- Kunstleve RW, Jiang JS, Kuszewski J, Nilges M, Pannu NS, Read RJ, Rice LM, Simonson T, Warren GL. 1998. Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. D. Biol. Crystallogr. 54:905-921.
45. Brünger AT. 1992. Free R value: a novel statistical quantity for assessing the accuracy of crystal structures. Nature 355:472- 475.
46. Emsley P, Lohkamp B, Scott WG, Cowtan K. 2010. Features and development of Coot. Acta Crystallogr. D. Biol. Crystallogr. 66:486 -501.
47. Wallace AC, Laskowski RA, Thornton JM. 1995. LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng. 8:127-134.
48. Chen VB, Arendall WB, III, Headd JJ, Keedy DA, Immormino RM, Kapral GJ, Murray LW, Richardson JS, Richardson DC. 2010. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. D. Biol. Crystallogr. 66:12-21.
49. Kleywegt GJ, Jones TA. 1997. Model building and refinement practice. Methods Enzymol. 277:208 -230.
50. DeLano WL. 2002. The PyMOL molecular graphics system. DeLano Scientific LLC, San Carlos, CA.
51. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE. 2004. UCSF Chimera-a visualization system for exploratory research and analysis. J. Comput. Chem. 25:1605-1612.
52. Krissinel E, Henrick K. 2004. Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions. Acta Crystallogr. D. Biol. Crystallogr. 60:2256 -2268.
53. Urzhumtseva L, Afonine PV, Adams PD, Urzhumtsev A. 2009. Crystallographic model quality at a glance. Acta Crystallogr. D. Biol. Crystallogr. 65:297-300.
54. Adams PD, Afonine PV, Bunkóczi G, Chen VB, Davis IW, Echols N, Headd JJ, Hung LW, Kapral GJ, Grosse-Kunstleve RW, McCoy AJ, Moriarty NW, Oeffner R, Read RJ, Richardson DC, Richardson JS, Terwilliger TC, Zwart PH. 2010. PHENIX: a comprehensive Pythonbased system for macromolecular structure solution. Acta Crystallogr. D. Biol. Crystallogr. 66:213-221.
55. Halder S, Ng R, Agbandje-McKenna M. 2012. Parvoviruses: structure and infection. Future Virol. 7:253-278.
56. Cotmore SF, Tattersall P. 2007. Parvoviral host range and cell entry mechanisms. Adv. Virus Res. 70:183-232.
57. Farr GA, Cotmore SF, Tattersall P. 2006. VP2 cleavage and the leucine ring at the base of the fivefold cylinder control pH-dependent externalization of both the VP1 N terminus and the genome of minute virus of mice. J. Virol. 80:161-171.
58. Farr GA, Tattersall P. 2004. A conserved leucine that constricts the pore through the capsid fivefold cylinder plays a central role in parvoviral infection. Virology 323:243-256.
59. Farr GA, Zhang LG, Tattersall P. 2005. Parvoviral virions deploy a capsid-tethered lipolytic enzyme to breach the endosomal membrane during cell entry. Proc. Natl. Acad. Sci. U. S. A. 102:17148 -17153.
60. Hafenstein S, Bowman VD, Sun T, Nelson CD, Palermo LM, Chipman PR, Battisti AJ, Parrish CR, Rossmann MG. 2009. Structural comparison of different antibodies interacting with parvovirus capsids. J. Virol. 83: 5556-5566.
61. Kaufmann B, López-Bueno A, Mateu MG, Chipman PR, Nelson CD, Parrish CR, Almendral JM, Rossmann MG. 2007. Minute virus of mice, a parvovirus, in complex with the Fab fragment of a neutralizing monoclonal antibody. J. Virol. 81:9851-9858.
62. Wikoff WR, Wang G, Parrish CR, Cheng RH, Strassheim ML, Baker TS, Rossmann MG. 1994. The structure of a neutralized virus: canine parvovirus complexed with neutralizing antibody fragment. Structure 2:595- 607.
63. López-Bueno A, Rubio MP, Bryant N, McKenna R, Agbandje-McKenna M, Almendral JM. 2006. Host-selected amino acid changes at the sialic acid binding pocket of the parvovirus capsid modulate cell binding affinity and determine virulence. J. Virol. 80:1563-1573.
64. Barbis DP, Chang SF, Parrish CR. 1992. Mutations adjacent to the dimple of the canine parvovirus capsid structure affect sialic acid binding. Virology 191:301-308.
65. Allaume X, El-Andaloussi N, Leuchs B, Bonifati S, Kulkarni A, Marttila T, Kaufmann JK, Nettelbeck DM, Kleinschmidt J, Rommelaere J, Marchini A. 2012. Retargeting of rat parvovirus H-1PV to cancer cells through genetic engineering of the viral capsid. J. Virol. 86:3452-3465.
66. D'Abramo AM, Jr, Ali AA, Wang F, Cotmore SF, Tattersall P. 2005. Host range mutants of minute virus of mice with a single VP2 amino acid change require additional silent mutations that regulate NS2 accumulation. Virology 340:143-154.
67. Etingov I, Itah R, Mincberg M, Keren-Naus A, Nam HJ, Agbandje- McKenna M, Davis C. 2008. An extension of the minute virus of mice tissue tropism. Virology 379:245-255.
68. Paglino J, Tattersall P. 2011. The parvoviral capsid controls an intracellular phase of infection essential for efficient killing of stepwisetransformed human fibroblasts. Virology 416:32- 41.
69. Paglino JC, Ozduman K, van den Pol AN. 2012. LuIII parvovirus selectively and efficiently targets, replicates in, and kills human glioma cells. J. Virol. 86:7280 -7291.
70. de Oliveira OV, de Moura AF, Freitas LCG. 2007. A mechanism for the stabilization of the secondary structure of a peptide by liquid ethylene glycol and its aqueous solutions. J. Mol. Struct. Theochem. 808:93-96.
71. Weiss MS, Jabs A, Hilgenfeld R. 1998. Peptide bonds revisited. Nat. Struct. Biol. 5:676.
72. Brandts JF, Halvorson HR, Brennan M. 1975. Consideration of the possibility that the slow step in protein denaturation reactions is due to cis-trans isomerism of proline residues. Biochemistry 14:4953- 4963.
73. Kelly BN, Kyere S, Kinde I, Tang C, Howard BR, Robinson H, Sundquist WI, Summers MF, Hill CP. 2007. Structure of the antiviral assembly inhibitor CAP-1 complex with the HIV-1 CA protein. J. Mol. Biol. 373:355-366.
74. Golmohammadi R, Valegård K, Fridborg K, Liljas L. 1993. The refined structure of bacteriophage MS2 at 2.8 Å resolution. J. Mol. Biol. 234:620- 639.
75. Pérez R, Castellanos M, Rodríguez-Huete A, Mateu MG. 2011. Molecular determinants of self-association and rearrangement of a trimeric intermediate during the assembly of a parvovirus capsid. J. Mol. Biol. 413: 32-40.
76. Reguera J, Carreira A, Riolobos L, Almendral JM, Mateu MG. 2004. Role of interfacial amino acid residues in assembly, stability, and conformation of a spherical virus capsid. Proc. Natl. Acad. Sci. U. S. A. 101:2724- 2729.
77. Riolobos L, Reguera J, Mateu MG, Almendral JM. 2006. Nuclear transport of trimeric assembly intermediates exerts a morphogenetic control on the icosahedral parvovirus capsid. J. Mol. Biol. 357:1026 -1038.
78. Cotmore SF, Hafenstein S, Tattersall P. 2010. Depletion of virionassociated divalent cations induces parvovirus minute virus of mice to eject its genome in a 3 ́-to-5 ́ direction from an otherwise intact viral particle. J. Virol. 84:1945-1956.
79. Cotmore SF, Tattersall P. 2012. Mutations at the base of the icosahedral five-fold cylinders of minute virus of mice induce 3 ́-to-5 ́ genome uncoating and critically impair entry functions. J. Virol. 86:69-80.
80. Batra VK, Beard WA, Shock DD, Krahn JM, Pedersen LC, Wilson SH. 2006. Magnesium-induced assembly of a complete DNA polymerase catalytic complex. Structure 14:757-766.
81. Galburt EA, Chevalier B, Tang W, Jurica MS, Flick KE, Monnat RJ, Jr, Stoddard BL. 1999. A novel endonuclease mechanism directly visualized for I-PpoI. Nat. Struct. Biol. 6:1096 -1099.
82. Reguera J, Grueso E, Carreira A, Sánchez-Martínez C, Almendral JM, Mateu MG. 2005. Functional relevance of amino acid residues involved in interactions with ordered nucleic acid in a spherical virus. J. Biol. Chem. 280:17969 -17977.
83. Carrasco C, Carreira A, Schaap IA, Serena PA, Gómez-Herrero J, Mateu MG, de Pablo PJ. 2006. DNA-mediated anisotropic mechanical reinforcement of a virus. Proc. Natl. Acad. Sci. U. S. A. 103:13706 -13711.
84. Richards R, Linser P, Armentrout RW. 1977. Kinetics of assembly of a parvovirus, minute virus of mice, in synchronized rat brain cells. J. Virol. 22:778 -793.
85. Yuan W, Parrish CR. 2001. Canine parvovirus capsid assembly and differences in mammalian and insect cells. Virology 279:546 -557.
86. McKenna R, Ilag LL, Rossmann MG. 1994. Analysis of the singlestranded DNA bacteriophage φ X174, refined at a resolution of 3.0 Å. J. Mol. Biol. 237:517-543.
87. Theobald DL, Mitton-Fry RM, Wuttke DS. 2003. Nucleic acid recognition by OB-fold proteins. Annu. Rev. Biophys. Biomol. Struct. 32:115- 133.
88. Fisher AJ, Johnson JE. 1993. Ordered duplex RNA controls capsid architecture in an icosahedral animal virus. Nature 361:176 -179.
89. Lane SW, Dennis CA, Lane CL, Trinh CH, Rizkallah PJ, Stockley PG, Phillips SE. 2011. Construction and crystal structure of recombinant STNV capsids. J. Mol. Biol. 413:41-50.
90. Valegård K, Murray JB, Stockley PG, Stonehouse NJ, Liljas L. 1994. Crystal structure of an RNA bacteriophage coat protein-operator complex. Nature 371:623- 626.
91. Borodavka A, Tuma R, Stockley PG. 2012. Evidence that viral RNAs have evolved for efficient, two-stage packaging. Proc. Natl. Acad. Sci. U. S. A. 109:15769 -15774.
92. Bunka DH, Lane SW, Lane CL, Dykeman EC, Ford RJ, Barker AM, Twarock R, Phillips SE, Stockley PG. 2011. Degenerate RNA packaging signals in the genome of satellite tobacco necrosis virus: implications for the assembly of a TA1 capsid. J. Mol. Biol. 413:51- 65.
93. Helgstrand C, Grahn E, Moss T, Stonehouse NJ, Tars K, Stockley PG, Liljas L. 2002. Investigating the structural basis of purine specificity in the structures of MS2 coat protein RNA translational operator hairpins. Nucleic Acids Res. 30:2678 -2685.
94. Lago H, Fonseca SA, Murray JB, Stonehouse NJ, Stockley PG. 1998. Dissecting the key recognition features of the MS2 bacteriophage translational repression complex. Nucleic Acids Res. 26:1337-1344.
95. Stockley PG, Stonehouse NJ, Murray JB, Goodman ST, Talbot SJ, Adams CJ, Liljas L, Valegård K. 1995. Probing sequence-specific RNA recognition by the bacteriophage MS2 coat protein. Nucleic Acids Res. 23:2512-2518.
96. Zuker M. 2003. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 31:3406 -3415.